166 related articles for article (PubMed ID: 29576595)
21. Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis.
Aoyama N; Nishinari M; Ohtani S; Kanai A; Noda C; Hirata M; Miyamoto A; Watanabe M; Minamino T; Izumi T; Ako J
Heart Vessels; 2017 Sep; 32(9):1099-1108. PubMed ID: 28357515
[TBL] [Abstract][Full Text] [Related]
22. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans.
Huang PP; Yang XF; Li SZ; Wen JC; Zhang Y; Han ZC
Thromb Haemost; 2007 Dec; 98(6):1335-42. PubMed ID: 18064333
[TBL] [Abstract][Full Text] [Related]
23. A Multicenter Prospective Interventional Trial of Therapeutic Angiogenesis Using Bone Marrow-Derived Mononuclear Cell Implantation for Patients With Critical Limb-Threatening Ischemia Caused by Thromboangiitis Obliterans.
Fujioka A; Yanishi K; Yukawa A; Imai K; Yokota I; Fujikawa K; Yamada A; Naito A; Shoji K; Kawamata H; Higashi Y; Ishigami T; Sasaki KI; Tara S; Kuwahara K; Teramukai S; Matoba S
Circ J; 2023 Aug; 87(9):1229-1237. PubMed ID: 36908168
[TBL] [Abstract][Full Text] [Related]
24. Safety and Efficacy of Repeated Bone Marrow Mononuclear Cell Therapy in Patients with Critical Limb Ischemia in a Pilot Randomized Controlled Trial.
Molavi B; Zafarghandi MR; Aminizadeh E; Hosseini SE; Mirzayi H; Arab L; Baharvand H; Aghdami N
Arch Iran Med; 2016 Jun; 19(6):388-96. PubMed ID: 27293053
[TBL] [Abstract][Full Text] [Related]
25. A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia.
Gupta PK; Chullikana A; Parakh R; Desai S; Das A; Gottipamula S; Krishnamurthy S; Anthony N; Pherwani A; Majumdar AS
J Transl Med; 2013 Jun; 11():143. PubMed ID: 23758736
[TBL] [Abstract][Full Text] [Related]
26. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia.
Higashi Y; Kimura M; Hara K; Noma K; Jitsuiki D; Nakagawa K; Oshima T; Chayama K; Sueda T; Goto C; Matsubara H; Murohara T; Yoshizumi M
Circulation; 2004 Mar; 109(10):1215-8. PubMed ID: 15007007
[TBL] [Abstract][Full Text] [Related]
27. Cell therapy in critical limb ischemia: A comprehensive analysis of two cell therapy products.
Tournois C; Pignon B; Sevestre MA; Al-Rifai R; Creuza V; Poitevin G; François C; Nguyen P
Cytotherapy; 2017 Feb; 19(2):299-310. PubMed ID: 27914820
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.
Tateishi-Yuyama E; Matsubara H; Murohara T; Ikeda U; Shintani S; Masaki H; Amano K; Kishimoto Y; Yoshimoto K; Akashi H; Shimada K; Iwasaka T; Imaizumi T;
Lancet; 2002 Aug; 360(9331):427-35. PubMed ID: 12241713
[TBL] [Abstract][Full Text] [Related]
29. A novel therapeutic management for diabetes patients with chronic limb-threatening ischemia: comparison of autologous bone marrow mononuclear cells versus allogenic Wharton jelly-derived mesenchymal stem cells.
Arango-Rodríguez ML; Mateus LC; Sossa CL; Becerra-Bayona SM; Solarte-David VA; Ochoa Vera ME; Viviescas LTG; Berrio AMV; Serrano SE; Vargas O; Isla AC; Benitez A; Rangel G
Stem Cell Res Ther; 2023 Aug; 14(1):221. PubMed ID: 37626416
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb.
Zhang H; Zhang N; Li M; Feng H; Jin W; Zhao H; Chen X; Tian L
Ann Vasc Surg; 2008 Mar; 22(2):238-47. PubMed ID: 18083329
[TBL] [Abstract][Full Text] [Related]
31. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.
Moazzami K; Majdzadeh R; Nedjat S
Cochrane Database Syst Rev; 2011 Dec; (12):CD008347. PubMed ID: 22161427
[TBL] [Abstract][Full Text] [Related]
32. Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI).
Amann B; Lüdemann C; Rückert R; Lawall H; Liesenfeld B; Schneider M; Schmidt-Lucke J
Vasa; 2008 Nov; 37(4):319-25. PubMed ID: 19003741
[TBL] [Abstract][Full Text] [Related]
33. Relationship between cell number and clinical outcomes of autologous bone-marrow mononuclear cell implantation in critical limb ischemia.
Yusoff FM; Kajikawa M; Takaeko Y; Kishimoto S; Hashimoto H; Maruhashi T; Nakashima A; Wahid SFSA; Higashi Y
Sci Rep; 2020 Nov; 10(1):19891. PubMed ID: 33199760
[TBL] [Abstract][Full Text] [Related]
34. Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.
Amann B; Luedemann C; Ratei R; Schmidt-Lucke JA
Cell Transplant; 2009; 18(3):371-80. PubMed ID: 19500466
[TBL] [Abstract][Full Text] [Related]
35. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans.
Durdu S; Akar AR; Arat M; Sancak T; Eren NT; Ozyurda U
J Vasc Surg; 2006 Oct; 44(4):732-9. PubMed ID: 16926085
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
[TBL] [Abstract][Full Text] [Related]
37. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.
Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T
Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453
[TBL] [Abstract][Full Text] [Related]
38. Review of the Long-term Effects of Autologous Bone-Marrow Mononuclear Cell Implantation on Clinical Outcomes in Patients with Critical Limb Ischemia.
Yusoff FM; Kajikawa M; Matsui S; Hashimoto H; Kishimoto S; Maruhashi T; Chowdhury M; Noma K; Nakashima A; Kihara Y; Sueda T; Higashi Y
Sci Rep; 2019 May; 9(1):7711. PubMed ID: 31118440
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia.
Lara-Hernandez R; Lozano-Vilardell P; Blanes P; Torreguitart-Mirada N; Galmés A; Besalduch J
Ann Vasc Surg; 2010 Feb; 24(2):287-94. PubMed ID: 20142004
[TBL] [Abstract][Full Text] [Related]
40. Purified CD34
Dong Z; Pan T; Fang Y; Wei Z; Gu S; Fang G; Liu Y; Luo Y; Liu H; Zhang T; Hu M; Guo D; Xu X; Chen B; Jiang J; Yang J; Shi Z; Zhu T; Shi Y; Liu P; Fu W
EBioMedicine; 2018 Sep; 35():46-57. PubMed ID: 30172703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
